AGP Executive Report
Last update: 7 hours agoLocal Access: Macao Union Medical Center will start a weekday shuttle between its hospital and Seac Pai Van Health Centre on Nov. 23, with five daily trips from the centre and four return trips to serve patients. Metabolic Health: Innogen Pharmaceuticals has signed an international licensing deal for efsubaglutide alfa, its GLP-1 treatment for type 2 diabetes and obesity. The therapy is approved for type 2 diabetes in Macao. Medical Research: A University of Macau graduate has developed an AI-powered genetic testing platform aimed at hereditary disease screening and precision medicine.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.